JSJonathon J. Stone

Jonathon J. Stone

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jonathon J. Stone has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Diagnostic challenge in veterinary pathology: A large vesicle-containing, membrane-bound structure in the myocardium of a cat with cardiomyopathy

    by Annie L. Showers, Sara E. Miller, Gregory M. Hendricks, Katherine E. Lopez, Esther Gisela Martinez-Romero, Amanda J. Martinot, Jonathan A. Runstadler, John E. Rush, Kaitlin Sawatzki, Keith R. Reddig, et al.

  • An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaques

    by Ninaad Lasrado, Liping Wang, Jinyan Liu, Annika Rössler, Jayeshbhai Chaudhari, Qixin Wang, Jonathon J. Stone, Francisco Armando Granados-Contreras, Jessica Wu, Dalia N. Cabrera-Barragan, et al.

    The H5N1 clade 2.3.4.4b avian influenza virus outbreak in poultry and dairy cattle is a potential pandemic threat for humans. A safe and effective H5N1 influenza vaccine will be needed if the virus acquires the capacity for efficient human-to-human transmission and may also be useful as a veterinary vaccine. In this study, we demonstrate robust vaccine protection in a lethal model of H5N1 clade 2.3.4.4b influenza infection in cynomolgus macaques. We vaccinated 24 cynomolgus macaques with mRNA or rhesus adenovirus serotype 52 (RhAd52) vaccines expressing the hemagglutinin (HA) from H5N1 clade 2.3.4.4b by the intramuscular or intratracheal route and challenged them with the H5N1 human isolate hu-TX37-H5N1. Of sham control animals, 83% (five of six) developed severe rapidly progressive consolidative pneumonia and were euthanized by days 5 to 7 after challenge. In contrast, 100% (17 of 17) of vaccinated macaques survived and controlled virus replication to undetectable titers in both the upper and lower respiratory tracts by days 4 to 14 after challenge. Mucosal boosting with the RhAd52 HA vaccine generated robust mucosal antibody and T cell responses and afforded 6.3 and 5.1 log 10 median viral load reductions in viral RNA with no detectable infectious virus titers compared with sham controls in bronchoalveolar lavage and nasal swabs, respectively. These data demonstrate that an adenovirus-vectored vaccine can protect against lethal H5N1 clade 2.3.4.4b challenge in nonhuman primates and further highlight the importance of vaccine-elicited mucosal immunity.


  • Open Access

    Outbreak of Highly Pathogenic Avian Influenza H5N1 in New England Seals

    by Wendy Puryear, Kaitlin Sawatzki, Nichola Hill, Alexa Foss, Jonathon J. Stone, Lynda Doughty, Dominique Walk, Katie Gilbert, Maureen Murray, Elena Cox, et al.

    The recent incursion of Highly Pathogenic Avian Influenza A (H5N1) virus into North America and subsequent dissemination of virus across the continent, has had significant adverse impacts on domestic poultry, and has led to widespread mortality in many wild bird species. Here we report the recent spillover of H5N1 into marine mammals in the northeastern United States, with associated mortality on a regional scale. This spillover is coincident with a second wave of H5N1 in sympatric wild birds also experiencing regional mortality events. Viral sequences derived from both seal and avian hosts reveal distinct viral genetic differences between the two waves of infection. Spillover into seals was closely related to virus from the second wave, and one of eight seal-derived sequences had the mammalian adaptation PB2 E627K. One-Sentence Summary An outbreak of H5N1 in New England seals is the first known population-scale mammalian mortality event associated with the emerging highly pathogenic avian influenza clade 2.3.4.4b.


  • Open Access

    Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting

    by Kaitlin Sawatzki, Nichola J. Hill, Wendy B. Puryear, Alexa D. Foss, Jonathon J. Stone, Jonathan A. Runstadler

    Ferrets (Mustela putorius furo) are mustelids of special relevance to laboratory studies of respiratory viruses and have been shown to be susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and onward transmission. Here, we report the results of a natural experiment where 29 ferrets in one home had prolonged, direct contact and constant environmental exposure to two humans with symptomatic disease, one of whom was confirmed positive for SARS-CoV-2. We observed no evidence of SARS-CoV-2 transmission from humans to ferrets based on viral and antibody assays. To better understand this discrepancy in experimental and natural infection in ferrets, we compared SARS-CoV-2 sequences from natural and experimental mustelid infections and identified two surface glycoprotein Spike (S) mutations associated with mustelids. While we found evidence that angiotensin-converting enzyme II provides a weak host barrier, one mutation only seen in ferrets is located in the novel S1/S2 cleavage site and is computationally predicted to decrease furin cleavage efficiency. These data support the idea that host factors interacting with the novel S1/S2 cleavage site may be a barrier in ferret SARS-CoV-2 susceptibility and that domestic ferrets are at low risk of natural infection from currently circulating SARS-CoV-2. We propose two mechanistically grounded hypotheses for mustelid host adaptation of SARS-CoV-2, with possible effects that require additional investigation. Significance Ferrets have been demonstrated to be susceptible to laboratory infection of SARS-CoV-2, raising the possibility of natural transmission from humans into their pets in domestic settings. We demonstrate that ferrets may have host barriers that limit natural infection and transmission. First, we find no evidence of infection in 29 ferrets from a home with constant exposure to two adults with one confirmed and one suspected case of symptomatic COVID-19. Second, we analyze genetic sequences from viruses and hosts and demonstrate that ferrets have genetic factors that confer resistance to natural SARS-CoV-2 infection. These data suggest that ferret infection may require viral adaptation, and therefore ferrets may only be semipermissive models of SARS-CoV-2 disease or transmission.


  • Open Access

    Quantitative assessment of human donor corneal endothelium with Gabor domain optical coherence microscopy

    by Changsik Yoon, Amanda Mietus, Yue Qi, Jonathon J. Stone, Johana C. Escudero, Cristina Canavesi, Patrice Tankam, Holly B. Hindman, Jannick P. Rolland

    The corneal endothelium is the innermost layer of the cornea, which serves as a leaky barrier to aqueous humor flow that supplies the stroma with necessary nutrients. Corneal transparency is maintained by healthy endothelial cells (ECs) that contain fluid pumps that control the level of stromal hydration.1 A malfunction in the deturgescence state of the cornea can lead to corneal edema and eventually to blindness. From penetrating keratoplasty, first developed in 1905, to endothelial keratoplasty,2,3 corneal transplantation remains the main method of treatment for endothelial dysfunction and failure.4 Endothelial cell density (ECD) is a key determinant in tissue selection/placement and graft survival.